Investor Portal

Strategic Capital
and Advice for
Complex Situations.

Apotheo is a private capital and investment banking firm led by owners with decades of experience navigating complex, high-stakes transactions. We bring a principal's perspective to every engagement, delivering tailored solutions for our investors, partners, and clients. We focus on opportunities where we believe that our involvement will maximize alignment and outcomes.

$550B+*

Transaction value completed

150+*

Transactions closed

20+

Years Average
Senior Experience

Begin a conversation

* Figures represent cumulative transaction experience of firm professionals.

Our Value Proposition

Advice. Capital.
Integrated solutions.


Apotheo Capital is a financial advisory and private capital firm focused on delivering creative, purpose-built solutions that address the specific needs of our investors, partners and clients, particularly in situations where access to capital is challenging.

Advisory

Financial Advisory Services

  • Innovative approaches for companies and creditors on intricate M&A, capital solutions and financing transactions
  • Deep Liability Management expertise; exchange offers, waivers & amendments, debt repurchases, restructurings, and consent solicitations
  • Advise with an investor mindset focused on aligning incentives and maximizing value

Investing

Private Capital

  • Private equity and capital solutions for businesses where potential is being masked by business, industry, or structural complexity
  • Investment themes include corporate carve-outs, distressed assets, family-owned businesses, and asset-backed finance, as well as out-of-favor and hung sale processes that others overlook
  • Flexible approach across the capital structure
  • Long-lived investment horizon, unencumbered by traditional fund constraints

Integrated

Capital and Advice, Working Together

  • Differentiated approach: leverage both private capital and advisory skills to advise on and invest in structured transactions and financings
  • Highly creative transaction structuring for fraught and unconventional situations
  • Flexibility on remuneration to align long-term interests with clients and partners

Why Apotheo

Aligned interests.
Unconflicted advice.


Apotheo Capital was founded on a straightforward belief: the best outcomes come when advisors and investors share the same incentives as their clients, whether advising, investing, or doing both. We take on a focused number of mandates, engaging senior professionals at every stage and bringing creative, unconventional thinking to challenging situations where conventional approaches have fallen short.

Selectivity & Senior Attention

We engage selectively, and only where we believe we can make a meaningful impact. Every situation receives the full attention of our senior team from initial evaluation through execution, bringing the judgment that comes from decades of experience advising on and investing in complex capital structures.

Investor Mindset Meets Advisory Expertise

Apotheo combines active principal investing experience with financial advisory. We evaluate every engagement through the lens of investors allocating real capital, bringing a depth of judgment and commercial perspective that purely fee-driven advisors cannot replicate.

Clear Alignment of Incentives

Our economics are designed to reflect outcomes. We structure engagements so that a meaningful portion of compensation is tied to value realized, aligning our incentives with those of our clients and capital partners.

Discreet, Boutique Platform

Our size is a strategic advantage. We operate discreetly, protecting client confidentiality while navigating complex stakeholder dynamics across companies, lenders, and investors in sensitive situations.

Proven at the Highest Level

The Apotheo team has led some of the most complex capital structure transactions in recent history (~$550 billion in value), earning multiple industry recognitions along the way. Clients receive the sophistication and judgment of a top-tier platform, without the bureaucracy or diffusion of attention.

Flexible Capital for Unconventional Solutions

Complexity is our asset class. Apotheo invests in situations that stymie conventional investors, where value is real but obscured, and where patient, independent capital makes the difference.

Our Team

Principals with proven track records at the highest level.


Ari Lefkovits

+

Ari Lefkovits is Managing Partner of Apotheo. Prior to founding Apotheo, Ari was a Managing Partner at Delos Capital, where he focused on special situations and private investments. Before Delos, Ari spent more than two decades at Lazard, where he was a Managing Director advising on capital solutions, restructuring, and liability management transactions totaling over $300 billion.

Ari has over 25 years of experience advising investors, senior executives, and boards of directors on complex corporate finance matters. During his tenure at Lazard, he worked in both the New York and London offices and advised on many of the firm's largest and most complex engagements, receiving multiple industry awards in the process.

He has advised companies, boards, creditors, investors, unions, and government entities across a wide range of situations, including mergers and acquisitions, restructurings and reorganizations, debt exchanges and other liability management transactions, spin-offs, debt and equity financings, and joint ventures.

Ari has testified before the U.S. Bankruptcy Court, various state courts, and the New York Stock Exchange. He speaks frequently on industry panels and in the press and has been recognized as one of Turnarounds & Workouts' "People to Watch" and one of The M&A Advisor's "40 Under 40" corporate finance professionals.

Ari holds an A.B. from Dartmouth College and a J.D. from Stanford Law School.

Ari is a Registered Representative of BA Securities, LLC.

Alice Chong

+

Alice Chong is a co-founder of Apotheo. She has extensive experience advising companies, governments, and other stakeholders on complex restructuring, M&A, and financing transactions across a broad range of industries.

Prior to Apotheo, Alice was a Managing Director in the restructuring group at Guggenheim Securities. She also worked at Delos Capital, where she focused on special situations advisory, partnering with companies and stakeholders on complex transactions and tailored capital solutions.

Earlier in her career, Alice held roles at Millstein & Co., Duff & Phelps, and Lazard, where she advised companies and creditors on restructuring and strategic transactions. She began her career at Lazard focusing on mergers and acquisitions advisory in the Technology, Media, and Telecommunications sectors.

She received a B.S. in Business Administration and a B.A. in Political Science from University of California, Berkeley.

Alice Chong is a Registered Representative of BA Securities, LLC.

Jay Losty

+

Jay Losty is a co-founder of Apotheo. He focuses on private investments and capital solutions advisory in complex situations across a range of industries.

Prior to Apotheo, Jay spent several years at Delos Capital, where he worked across private investments and special situations advisory, including partnering with portfolio company management teams on strategic initiatives, acquisitions, and recapitalizations. He previously worked in the Investment Banking Division at Goldman Sachs, where he executed financing transactions across leveraged finance, structured finance, and investment grade markets for corporate and financial sponsor clients.

Jay earned a B.A. in History from Yale University and completed advanced Mandarin studies at the International Chinese Language Program at National Taiwan University.

Jay Losty is a Registered Representative of BA Securities, LLC.

Ross Weiner

+

Ross Weiner has over 30 years of experience as an investor and advisor across credit markets, restructurings, and special situations.

Prior to joining Apotheo, Ross served as a Senior Advisor at Searchlight Capital Partners, where he sourced and evaluated investment opportunities for the firm's Credit Opportunities strategy and advised on portfolio positions.

Previously, Ross was an investment manager at Millennium Management, where he led opportunistic and event-driven investments across credit and equity markets. Earlier in his career he held investment roles at Trilogy Capital Management, Litespeed Management, and Gracie Capital, managing portfolios focused on distressed debt, leveraged loans, and special situations.

Earlier in his career, Ross was a Managing Director in the High Yield and Bankruptcy Group at Bear, Stearns & Co. and began his career in restructuring and high yield investment banking at Alex. Brown & Sons.

Ross earned a B.S. in Economics and Industrial Management from Carnegie Mellon University.

Ross Weiner is a Registered Representative of BA Securities, LLC.

Kate Ditchfield

+

Kate Ditchfield serves as Chief of Staff at Apotheo, where she supports firm leadership across strategic priorities, operational execution, and internal coordination.

Kate works closely with the firm's partners to translate strategic initiatives into structured execution, overseeing key operational processes and helping coordinate initiatives across advisors, partners, and stakeholders.

Prior to joining Apotheo, Kate held roles supporting senior executives and founders, focusing on operational strategy, business development coordination, and leadership support in high-growth organizations.

Our Advisors

Senior advisors providing strategic insight and invaluable expertise.


Marcia Goldstein

+

Marcia Goldstein is a Senior Advisor to Apotheo.

Marcia has over four decades of experience advising companies, boards, creditors, and other stakeholders on some of the most complex restructuring and turnaround situations globally. She previously served as a senior partner at Weil, Gotshal & Manges, where she was Chair of the Business Finance & Restructuring Department and a member of the Firm's Management Committee.

Over the course of her career, Marcia has led numerous high-profile domestic and international restructurings and has advised boards of directors across both public and private companies in navigating periods of financial distress and transformation. Her experience spans crisis management, corporate governance, and complex multi-stakeholder negotiations.

Marcia is widely recognized as one of the leading restructuring advisors globally, having been named among the "100 Most Influential Lawyers in America" and receiving multiple lifetime achievement and industry awards.

She has lectured at leading institutions including Yale, Harvard, Columbia, NYU, and Cornell, and remains active in a number of academic and nonprofit organizations.

Marcia earned a B.A., magna cum laude, from Cornell University and a J.D., cum laude, from Cornell Law School.

Stephen Sands

+

Stephen Sands is a Senior Advisor to Apotheo.

Stephen has over 35 years of experience advising C-suite executives and boards at leading global healthcare companies. He previously served as Vice Chairman of Investment Banking and Chairman of Global Healthcare at Lazard, where he advised on more than 180 M&A transactions and 130 financings totaling over $500 billion, including numerous innovative and cross-border transactions. Prior to Lazard, he was a Partner in the healthcare practice at McKinsey & Company.

Over the course of his career, Stephen has also co-founded two life sciences companies, Enzytech (acquired by Alkermes) and Opta Food Ingredients (acquired by Stake Technology, now part of SunOpta). He has served on the boards of multiple life sciences companies and currently serves as a director of Bicycle Therapeutics and Recordati.

Stephen is a frequent speaker on trends in the biopharmaceutical and healthcare sectors and is active in a number of academic and research institutions. He has received multiple industry and alumni honors, including the New York Biotechnology Association's Business Leader of the Year Award.

Stephen earned a B.A. in Biology from Oberlin College, a B.S. and M.S. in Chemical Engineering from Washington University in St. Louis, and an MBA in Finance from New York University.

Our Name

Apotheo /æpəˈθiːoʊ/ prop. n.

From the ancient Greek verb  apotheóō: to elevate to the highest level, to the ideal form

We chose Apotheo because we work through noise, tension, and distress to transform a complex situation. Our purpose is to absorb the whole when others see only their corner, to find clarity within the complexity, and to bring the greatest outcome into being. We listen, dig, and digest, and then we act. We measure ourselves by what we make possible for our clients, investors, partners, and team.

Contact

Begin a conversation.


We work with a select group of clients and partners on transactions where our involvement meaningfully moves the needle. If you are exploring a circumstance where access to capital is challenging, including a merger or acquisition, restructuring, financing, or an investment partnership, we welcome the conversation.

Location

120 5th Avenue, Floor 3
New York, NY 10011

General Inquiries

info@apotheocap.com

Press Inquiries

press@apotheocap.com

Investor Portal

Sign in to your
account.

Incorrect email or password.